企業プロフィール

Galera Therapeutics 株価・ニュース・カタリスト

ティッカー:
GRTX
取引所:
NASDAQ
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

17.60 USD (-2.22%)

終値

最終更新: 2026年7月10日

時価総額

株価変動の要因

Current closing-price context is not available for GRTX.

企業概要

事業概要

Galera Therapeutics was a biotech company focused on oncology supportive care and radiation-related therapies before its restructuring and decline. Its legacy was centered on protecting patients during cancer treatment.

所在地とセクター分類

Headquartered in the United States and listed on NASDAQ before restructuring, Galera sat in specialty oncology biotechnology.

ビジネスモデルの特徴

The business depended on clinical development, regulatory steps, and the challenge of translating supportive-care science into a durable franchise.

バイオ業界での位置付け

Galera belongs to the historical oncology-biotech group rather than the current live public-company set.

今後のカタリスト

  • Galera is now largely a legacy and closeout story, so the catalysts are corporate resolution rather than a fresh pipeline readout. The market is focused on what value remains after the prior oncology effort.

最近のニュース

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

類似銘柄

事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。